KIT and non-small cell lung carcinoma: c-KIT overexpression is well recognized in numerous malignancies, including SCLC [80], as well as melanoma [81], non-small-cell lung cancer (NSCLC) [82], acute myelogenous leukemia (AML) [83], and gastrointestinal stromal tumors (GIST) [84].